(VIANEWS) – Shares of Catalyst Pharmaceuticals (NASDAQ Composite: CPRX) rose 5.02% to $6.48 at 11:12 EST on Wednesday, after two sequential sessions in a row of losses. NASDAQ Composite is dropping 0.23% to $15,849.22, following the last session’s downward trend. This seems, up until now, a somewhat bearish trend trading session today.

Catalyst Pharmaceuticals’s last close was $6.17, 6.52% below its 52-week high of $6.60.


Today’s last reported volume for Catalyst Pharmaceuticals is 339696 which is 59.26% below its average volume of 833926.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 18% for the present quarter and 15.6% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.


Catalyst Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a negative 0.48%, a negative 0.03%, and a positive 2.19%, respectively.

Catalyst Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.23% (last week), 1.58% (last month), and 2.19% (last quarter), respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $6.48 at 11:12 EST, under its 52-week high of $6.60 and way above its 52-week low of $3.22.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is way higher than its 50-day moving average of $5.81 and way above its 200-day moving average of $5.56.

More news about Catalyst Pharmaceuticals (CPRX).


Please enter your comment!
Please enter your name here